1. Market Research
  2. > Pharmaceutical
  3. > Drug and Medication Market Trends
  4. > Drug and Medication Analysis & Statistics in France, July 2013 (p3)

Drug and Medication Analysis & Statistics in France, July 2013 (p3)

61-82 of 82 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Chronic Heart Failure - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Heart Failure - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • June 2013
  • by Global Data

PharmaPoint: Chronic Heart Failure - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure - France Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Non-Small Cell Lung Cancer - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Non-Small Cell Lung Cancer - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • June 2013
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - France Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in ...

  • Industries : Drug and Medication
  • Countries : France
Laboratoires McNeil in Consumer Health (France)

Laboratoires McNeil in Consumer Health (France)

  • $ 143
  • Company report
  • June 2013
  • by Euromonitor International

Laboratoires McNeil is a Johnson & Johnson Inc company. This manufacturer is present in several categories, such as digestive remedies, analgesics, eye care, dermatologicals and NRT smoking cessation aids. ...

  • Industries : Drug and Medication
  • Countries : France
Novartis Group France SA in Consumer Health (France)

Novartis Group France SA in Consumer Health (France)

  • $ 143
  • Company report
  • June 2013
  • by Euromonitor International

Novartis Group France is likely to pursue the vision set at group level by Novartis AG in Switzerland. With a strong focus on eye care noted at group level, it is likely that the company will attempt to ...

  • Industries : Drug and Medication, Healthcare
  • Countries : France
Cooperation Pharmaceutique Francaise SAS (Cooper) in Consumer Health (France)

Cooperation Pharmaceutique Francaise SAS (Cooper) in Consumer Health (France)

  • $ 143
  • Company report
  • June 2013
  • by Euromonitor International

Cooper’s strategy will focus on the development and promotion of strong brands in the French consumer health market. It will also continue to consolidate its well-known products, such as the Pouxit range ...

  • Industries : Drug and Medication
  • Countries : South Africa, Saudi Arabia, France
Pierre Fabre SA, Laboratoires in Consumer Health (France)

Pierre Fabre SA, Laboratoires in Consumer Health (France)

  • $ 143
  • Company report
  • June 2013
  • by Euromonitor International

Pierre Fabre Group’s strategic vision is to expand further in the international arena, especially in emerging countries such as China, Brazil and Turkey. The focus is on dermo-cosmetic international ...

  • Industries : Drug and Medication
  • Countries : South Africa, Saudi Arabia, France
UPSA, Laboratoires in Consumer Health (France)

UPSA, Laboratoires in Consumer Health (France)

  • $ 143
  • Company report
  • June 2013
  • by Euromonitor International

Laboratoires UPSA will continue to focus on those consumer health categories in which it has a strong position. As a key part of its strategy, advertising and communication will continue to remain strong ...

  • Industries : Drug and Medication, Healthcare
  • Countries : France
Ear Care in France

Ear Care in France

  • $ 992
  • Industry report
  • June 2013
  • by Euromonitor International

In September 2012, Otipax, a common ear care product in France, was fully delisted from the official reimbursement list (listed at a 15% reimbursement rate until August 2012). This clearly confirms the ...

  • Industries : Healthcare
  • Countries : France
Emergency Contraception in France

Emergency Contraception in France

  • $ 992
  • Industry report
  • June 2013
  • by Euromonitor International

The contraceptive model in France drastically changed in recent years, with the advent of new hormonal methods of contraception, such contraceptive implants, contraceptive skin patches and vaginal rings. ...

  • Industries : Drug and Medication
  • Countries : France
2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs

2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 260-page report from Venture Planning Group provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : France
2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs

2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Drug and Medication
  • Countries : France
2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs

2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 247-page report from Venture Planning Group provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis ...

  • Industries : Pathology, Drug and Medication
  • Countries : France
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022”. ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication
  • Countries : France
PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022

PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2013
  • by Global Data

PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022”. Human ...

  • Industries : Drug and Medication, Pathology
  • Countries : France
Quad 2 (HIV) - Forecast and Market Analysis to 2022

Quad 2 (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Quad 2 (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Quad 2 (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency ...

  • Industries : Pathology, Drug and Medication
  • Countries : France, Germany, Italy, Spain, United Kingdom, Japan, Brazil, China
2013 French Hospital Infectious Disease Testing Market

2013 French Hospital Infectious Disease Testing Market

  • $ 2 900
  • Industry report
  • December 2012
  • by Venture Planning Group

This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: - Major issues pertaining ...

  • Industries : Drug and Medication
  • Countries : France
Future Horizons in the French Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

Future Horizons in the French Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

  • $ 5 900
  • Industry report
  • August 2012
  • by Venture Planning Group

Highlights Comprehensive 850-page market segmentation analysis of the French NAT market.Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, ...

  • Industries : Drug and Medication
  • Countries : France
The 2012 French Molecular Diagnostics Market

The 2012 French Molecular Diagnostics Market

  • $ 5 900
  • Industry report
  • March 2012
  • by Venture Planning Group

This report presents a comprehensive analysis of the French molecular diagnostics market, including:Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, ...

  • Industries : Drug and Medication, Pathology
  • Countries : France
French Nucleic Acid Testing Market

French Nucleic Acid Testing Market

  • $ 5 900
  • Industry report
  • August 2011
  • by Venture Planning Group

Highlights Comprehensive 850-page market segmentation analysis of the French NAT market.Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, ...

  • Industries : Drug and Medication
  • Countries : France
About 200 reports

Download Unlimited Documents from Trusted Public Sources

Methotrexate Markets in France

  • February 2015
    4 pages
  • Methotrexate  

  • France  

View report >

Drug Industry - Forecast

December 2014

Drug Industry In France

November 2014

Pathology Description

August 2014

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.